Abdi, Jahangir <br/><br/>
Toll-like receptor (TLR)-1/2 triggering of multiple myeloma cells modulates their adhesion to bone marrow stromal cells and enhances bortezomib-induced apoptosis.  [electronic resource] 

 -  PloS one  2014 
 - e96608 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0096608  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Bone Marrow Cells--drug effects<br/>Boronic Acids--pharmacology<br/>Bortezomib<br/>Cell Adhesion--drug effects<br/>Cell Line, Tumor<br/>Humans<br/>Integrins--immunology<br/>Lipopeptides--pharmacology<br/>Multiple Myeloma--drug therapy<br/>Pyrazines--pharmacology<br/>Stromal Cells--drug effects<br/>Toll-Like Receptor 1--agonists<br/>Toll-Like Receptor 2--agonists